Reports of Patent, Design, and Trade Mark Cases, Issues 13-25Published at the Patent Office Sales Branch, 2007 - Industrial property |
From inside the book
Results 1-3 of 78
Page 506
... possible variety of avenues of research were indicated at best . The approaches described include the use of heparin ( conclusion : " It appears that heparin [ which had been delivered systemically , not via an eluting stent ] does not ...
... possible variety of avenues of research were indicated at best . The approaches described include the use of heparin ( conclusion : " It appears that heparin [ which had been delivered systemically , not via an eluting stent ] does not ...
Page 725
... possible date identified in the main panel of exhibit 1 , i.e. February 2003. Is it , for example , the date that the packaging was filled with its catheter , or the date by which the catheter must be used ? It is not clear whether or ...
... possible date identified in the main panel of exhibit 1 , i.e. February 2003. Is it , for example , the date that the packaging was filled with its catheter , or the date by which the catheter must be used ? It is not clear whether or ...
Page 779
... possible and where preparative columns were commercially available . ( v ) They would exclude columns which would plainly not work such as the Pirkle and ligand exchange columns . ( vi ) They would rapidly see there was a limited ...
... possible and where preparative columns were commercially available . ( v ) They would exclude columns which would plainly not work such as the Pirkle and ligand exchange columns . ( vi ) They would rapidly see there was a limited ...
Contents
EDITORS INTRODUCTION | v |
CASES REPORTED IN NUMERICAL ORDER | xiv |
CASES NOTED IN JUDGMENTS AND DECISIONS REPORTED | xxiv |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
added subject matter agreement Akzo Nobel Angiotech Pharmaceuticals Inc Appeal to Court application for revocation Appointed Person BACTIGUARD chiral citalopram claimants co-proprietor's application common general knowledge comparative advertising Comptroller consent Court of Appeal decision declarations of invalidity DESIGN AND TRADE divisional applications Dr Pinkava duties earlier mark earlier trade mark enantiomers European patents evidence grounds for refusal Halliburton Energy Services hearing officer Intellectual Property Office inventive step issue jurisdiction L'Oréal licence LIFFE likelihood of confusion Lundbeck Malynicz non-use opposition parallel trading particulars of infringement patentable subject matter Patents Act 1977 Patents Court perfumes pharmaceutical Playtech prior art racemate referred registered proprietor registered trade mark registrar relation relative grounds relevant REPORTS OF PATENT restenosis skilled person smell-alike specification stent Sweet & Maxwell taxol tibolone TRADE MARK 2007 Trade Mark Application trade marks declarations United Kingdom validating amendments VITALITE Vitasoy